Blog

Image with red blood cells in the background with words "Breaking News" in White

New Drug Approval Moves Us Closer To Long-Term Control of Multiple Myeloma

Image of red blood cells clusters in the background with "Breaking News" in White

FDA Approves First CAR T-Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

Researchers with masks working with test tubes in a lab

Highlights from ASCO 2021

Dr. Christopher Flowers, MD, chair of Lymphoma and Myeloma at U of Texas MD Anderson Cancer Center

Meet The Researcher: Dr. Christopher R. Flowers

Happy young man with arm around a young woman's shoulder--she is holding up her volunteer badge

Dare to Dream

Because You Volunteer, Your Impact Creates a Ripple Effect

Two medical professionals looking at a laptop computer

Navigating Your Care

FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma

The words 'Breaking News' over a background of red lymphoma cells as seen through a microscope

Another First: FDA Approves Car T-Immunotherapy for Treatment of Aggressive Form of Indolent Non-Hodgkin Lymphoma

Mom and baby girl (in hospital bed) wearing Rosie The Riveter outfits with We Can Do It sign

Honoring My Daughter’s Legacy By Continuing Her Fight

Dr. Rayne Rouce of Texas Children's Cancer Care Center

Meet The Researcher: Dr. Rayne Rouce

Aaron, cancer survivor, and a friend sitting at an outdoor table

Practicing Self-Advocacy During My PTCL Journey

Doctor talking to a child cancer patient getting treatment

Dare to Dream

Ushering In a New Era of Pediatric Blood Cancer Treatment and Care

myeloma-image.jpg

An Emerging Target for Myeloma Therapy Could Prove a Game-Changer

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.